A Phase II study of carboplatin and docetaxel followed by epstein-barr virus specific cytotoxic T Lymphocytes for refractory/relapsed EBV-positive nasopharyngeal carcinoma

✍ Scribed by Louis, C.U.; Ramos, C.; Kalra, M.; Glisson, B.; Liu, H.; Herzog, C.; Gee, A.; Heslop, H.E.; Brenner, M.K.; Rooney, C.; Gottschalk, S.

• Book ID: 123002048
• Publisher: Informa plc
• Year: 2013
• Tongue: English
• Weight: 58 KB
• Volume: 15
• Category: Article
• ISSN: 1465-3249
• DOI: 10.1016/j.jcyt.2013.01.030